Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant FVIII-Fc (FRSW107) in Hemophilia A – Phase III
CTR20201212Phase 3Completed
- Sponsor
- Kaifeng Pharmaceutical Group Co., Ltd
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Factor VIII in hemophilia A, sponsored by Kaifeng Pharmaceutical Group Co., Ltd. Started Jun 2020; status: completed.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20201212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201212.